Amwill Health Care Other Announcement
Amwill Health Care committed ₹3 Crore to Nippon India Credit Opportunities AIF Scheme II. The investment, funded from internal accruals, is drawn down in tranches.
- Value
- ₹3.00 Cr
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
7 announcements with these filters
Amwill Health Care committed ₹3 Crore to Nippon India Credit Opportunities AIF Scheme II. The investment, funded from internal accruals, is drawn down in tranches.
Amwill Health Care's board declared an interim dividend of Rs.0.05 per equity share for FY 2026-27 on 23 October 2026. The record date is 30 October 2026 and payment is proposed by 22 November 2026.
Amwill Health Care Ltd reported revenue from operations of ₹22.6 Cr (-7.0% YoY) and net profit of ₹3.7 Cr (-50.7% YoY) for H1 FY27.
Amwill Health Care has scheduled a board meeting for October 23, 2026, to review H1 financial results and consider declaring an interim dividend.
This filing is a standard quarterly Shareholding Pattern submission in accordance with SEBI Regulation 31(1)(b) for Amwill Health Care Ltd as of September 30, 2026.
Amwill Health Care received an import license from CDSCO for FoliColor hair products, enabling the company to commence commercial sale and import into India.
Amwill Health Care Limited approved investments of ₹3 Crore into two Alternative Investment Funds. The company will invest ₹1.50 Crore each in Vivriti Vihaan Trust and Neo Income Plus Fund III.